Moyra Lawrence

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 4

Top Topics

Escherichia Coli

Cardiac Surgery

Top Venues

Wellcome open research

Science advances

NPJ Regenerative medicine

University of Cambridge

University of Cambridge (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Cambridge Feb 28o 2017

United Kingdom

Postdoctoral research :: Haematology

Education History

University of Cambridge Oct 1o 2011 - Sep 30o 2014

United Kingdom

PHD :: Biochemistry

Publications

Cavan Bennett, Moyra Lawrence, Jose A Guerrero, Simon Stritt, Amie K Waller, Yahui Yan, Richard W Mifsud, José Ballester Beltrán, Ayesha Baig, Annett Mueller, Louisa Mayer, James Warland, Christopher J Penkett, Parsa Akbari, Thomas Moreau, Amanda L Evans, Souradip Mookerjee, Gary J Hoffman, Kourosh Saeb Parsy, David J Adams, Amber L Couzens, Markus Bender, Wendy N Erber, Bernhard Nieswandt, Randy J Read, Cedric Ghevaert
CRLF3 plays a key role in the final stage of platelet genesis and is a potential therapeutic target for thrombocythemia. Blood 139 (14) (2022)
Moyra Lawrence, Arash Shahsavari, Susanne Bornelöv, Thomas Moreau, Rebecca McDonald, Thomas M Vallance, Katarzyna Kania, Maike Paramor, James Baye, Marion Perrin, Maike Steindel, Paula Jimenez-Gomez, Christopher A Penfold, Irina I Mohorianu, Cedric Ghevaert
Mapping the biogenesis of forward programmed megakaryocytes from induced pluripotent stem cells. Science advances 8 (7) (2022)
Moyra Lawrence, Amanda Evans, Thomas Moreau, Marta Bagnati, Matthew Smart, Enas Hassan, Jahid Hasan, Monica Pianella, Julie Kerby, Cedric Ghevaert
Process analysis of pluripotent stem cell differentiation to megakaryocytes to make platelets applying European GMP. NPJ Regenerative medicine 6 (1) (2021)
Moyra Lawrence, Thorold W Theunissen, Patrick Lombard, David J Adams, José C R Silva
ZMYM2 inhibits NANOG-mediated reprogramming. Wellcome open research 4 (2019)